Vermont Rx discount program goes live

10 January 2001

The US state of Vermont's Pharmacy Discount Program went live January 1as planned, despite the lawsuit filed by the Pharmaceutical Research and Manufacturers of America against the Health Care Financing Administration, challenging the Medicaid law waiver granted by the HCFA to the state to allow the scheme to run (Marketletter December 18, 2000).

At January 1, about 300 applications from state residents to enrol in the program had been processed by the state Department of Human Services, which was continuing its efforts to enrol seniors and other state residents who lack prescription drug coverage, despite having heard that the court would be issuing an injunction order, according to Reuters reports. If such an injunction were made, "we obviously will respect it," said Department Commissioner Eileen Elliott.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight